Figure 2
From: Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma
Using pathway-based signatures of beta-adrenergic receptor regulation of the ERK pathway as prognosis predictor, Kaplan-Meier survival analysis of patients with lung adenocarcinoma were performed in all four training datasets (CAN/DF, HLM, UK and MSK) and in the two validation cohorts (GSE14814 and GSE1321).
